Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank43
3Y CAGR-5.8%
5Y CAGR+2.9%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-5.8%/yr
Annual compound
5Y CAGR
+2.9%/yr
Recent deceleration
Percentile
P43
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$39.20M-16.7%
2024$47.07M-40.1%
2023$78.59M+67.8%
2022$46.83M-35.7%
2021$72.83M+114.0%
2020$34.03M+1060.0%
2019$2.93M-
2018$0.00-